Published: February 3rd 2025 | Updated: March 4th 2025
Ocugen, Inc. receives European Medicines Agency ATMP designation for new gene therapy OCU400
Published: January 13th 2025 | Updated: February 5th 2025
Teva partners with Klinge Biopharma, Lotus Pharmaceutical for commercialisation of Formycon’s FYB203 (biosimilar aflibercept)
Published: January 31st 2024 | Updated: May 9th 2024
How biosimilars expand treatment options for patients with retinal disease
Published: March 12th 2025 | Updated: March 24th 2025
Her Royal Highness The Duchess of Edinburgh delivers keynote address on gender equity in eye care
Published: March 3rd 2025 | Updated: March 24th 2025
Study: Cigarette smoking negatively affects choroidal vascularity
Published: March 3rd 2025 | Updated: March 24th 2025
Cognition Therapeutics announces publication reviewing potential of zervimesine (CT1812) in dry AMD